Trial NCT03556202

View at ClinicalTrials.gov 
Org. Study IDs: 16491
Secondary IDs: 2017-003299-30 I6T-MC-AMAH

Last trial update was posted on 2023-03-21

MeSH Interventions

Mirikizumab

MeSH Conditions

Psoriasis

Other Conditions


Stopping Reasons

The study was terminated due to a strategic business decision made by the Sponsor.

Limitations And Caveats

This study was terminated before completion of the long-term extension trial, due to strategic business decision made by the company.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID